
| Salt Composition: | Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg) |
| Manufacturer: | NACC Pharmaceutical Pvt Ltd |
| Storage: | Below 25 degree celcius |
Out of Stock
Have doubts about this medicine?
Have doubts about this medicine?
Gliminac MV 2mg/500mg/0.3mg Tablet is a combination of medicines used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels. Gliminac MV 2mg/500mg/0.3mg Tablet belongs to a category of medicines known as anti-diabetic drugs. It is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Gliminac MV 2mg/500mg/0.3mg Tablet is a combination of three antidiabetic medicines:
What is Gliminac MV 2mg/500mg/0.3mg Tablet?
Gliminac MV 2mg/500mg/0.3mg Tablet is a combination medication consisting of glimepiride, metformin, and voglibose. It is used to treat type 2 diabetes mellitus (DM) in adults by improving blood glucose levels when combined with a proper diet and regular exercise.
What are the possible side effects of Gliminac MV 2mg/500mg/0.3mg Tablet?
Common side effects associated with the use of Gliminac MV 2mg/500mg/0.3mg Tablet include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash, and respiratory tract infection.
Are there any specific conditions in which Gliminac MV 2mg/500mg/0.3mg Tablet should not be taken?
Gliminac MV 2mg/500mg/0.3mg Tablet should be avoided in patients with a known allergy to its components or excipients, moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, and underlying metabolic acidosis including diabetic ketoacidosis.
Is it safe to take alcohol while I am also taking Gliminac MV 2mg/500mg/0.3mg Tablet?
No, consuming alcohol with Gliminac MV 2mg/500mg/0.3mg Tablet may lower your blood sugar levels and increase the risk of lactic acidosis.
Can the use of Gliminac MV 2mg/500mg/0.3mg Tablet cause hypoglycemia?
Yes, taking Gliminac MV 2mg/500mg/0.3mg Tablet can lead to hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. Regular monitoring of blood glucose levels is essential, especially when taking other medications or engaging in activities that lower blood sugar.
What are the instructions for the storage and disposal of Gliminac MV 2mg/500mg/0.3mg Tablet?
Store Gliminac MV 2mg/500mg/0.3mg Tablet in its original packaging, tightly closed, following the storage instructions provided on the label or pack. Dispose of unused medication properly to prevent consumption by pets, children, and other individuals.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Gliminac MV 2mg/500mg/0.3mg Tablet is to be taken empty stomach.
Alcohol
It is unsafe to consume alcohol with Gliminac MV 2mg/500mg/0.3mg Tablet.
Breastfeed
Gliminac MV 2mg/500mg/0.3mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Pregnancy
Gliminac MV 2mg/500mg/0.3mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.